Distinct K-ras mutation pattern characterizes signet ring cell colorectal carcinoma

Ignacio I. Wistuba, Carmen Behrens, Jorge Albores-Saavedra, Ruby Delgado, Francisco Lopez, Adi F. Gazdar

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Purpose: Signet ring cell colorectal carcinoma (SRCCC) represents a unique, infrequent, and highly malignant variant of colorectal cancer. To understand the pathogenesis of SRCCC, we investigated its molecular abnormalities and compared them with those of the usual type of colorectal adenocarcinoma. Experimental Design: Microdissected archival paraffin-embedded tissue from 16 SRCCCs and 27 non-SRCCCs was used to determine the frequency and pattern of mutation at codons 12, 13, and 61 of K-ras. A subset of tumors was examined for TP53 mutations at exons 5-8 and allele loss and genetic instability using seven microsatellite and two mononucleotide markers. Results: Comparable data on TP53 mutation, allele loss, and microsatellite instability were found between SRCCC and non-SRCCC. However, SRCCCs demonstrated a distinct pattern of K-ras mutation with a significantly lower frequency of mutations at codons 12 and 13 (13% versus 48%, P = 0.02) as compared with the non-SRCCCs. Four cases (25%) of SRCCC demonstrated the same A:T transversion at the third base position of K-ras codon 61 (CAA to CAT; Gln to His). No such point mutation was detected in non-SRCCCs or in the 30 gastric and 4 urinary bladder signet ring cell carcinomas examined. Conclusions: Our findings suggest that a distinct pattern of K-ras mutation is present in SRCCC, including a specific codon 61 mutation that has rarely been reported in human neoplasms.

Original languageEnglish (US)
Pages (from-to)3615-3619
Number of pages5
JournalClinical Cancer Research
Volume9
Issue number10 I
StatePublished - Oct 1 2003

Fingerprint

Signet Ring Cell Carcinoma
Colorectal Neoplasms
Mutation
Codon
Mutation Rate
Alleles
Microsatellite Instability
Point Mutation
Paraffin
Microsatellite Repeats
Exons
Neoplasms
Stomach
Urinary Bladder
Adenocarcinoma
Research Design

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Wistuba, I. I., Behrens, C., Albores-Saavedra, J., Delgado, R., Lopez, F., & Gazdar, A. F. (2003). Distinct K-ras mutation pattern characterizes signet ring cell colorectal carcinoma. Clinical Cancer Research, 9(10 I), 3615-3619.

Distinct K-ras mutation pattern characterizes signet ring cell colorectal carcinoma. / Wistuba, Ignacio I.; Behrens, Carmen; Albores-Saavedra, Jorge; Delgado, Ruby; Lopez, Francisco; Gazdar, Adi F.

In: Clinical Cancer Research, Vol. 9, No. 10 I, 01.10.2003, p. 3615-3619.

Research output: Contribution to journalArticle

Wistuba, II, Behrens, C, Albores-Saavedra, J, Delgado, R, Lopez, F & Gazdar, AF 2003, 'Distinct K-ras mutation pattern characterizes signet ring cell colorectal carcinoma', Clinical Cancer Research, vol. 9, no. 10 I, pp. 3615-3619.
Wistuba II, Behrens C, Albores-Saavedra J, Delgado R, Lopez F, Gazdar AF. Distinct K-ras mutation pattern characterizes signet ring cell colorectal carcinoma. Clinical Cancer Research. 2003 Oct 1;9(10 I):3615-3619.
Wistuba, Ignacio I. ; Behrens, Carmen ; Albores-Saavedra, Jorge ; Delgado, Ruby ; Lopez, Francisco ; Gazdar, Adi F. / Distinct K-ras mutation pattern characterizes signet ring cell colorectal carcinoma. In: Clinical Cancer Research. 2003 ; Vol. 9, No. 10 I. pp. 3615-3619.
@article{7431687da4f048e0ae336f2584f61830,
title = "Distinct K-ras mutation pattern characterizes signet ring cell colorectal carcinoma",
abstract = "Purpose: Signet ring cell colorectal carcinoma (SRCCC) represents a unique, infrequent, and highly malignant variant of colorectal cancer. To understand the pathogenesis of SRCCC, we investigated its molecular abnormalities and compared them with those of the usual type of colorectal adenocarcinoma. Experimental Design: Microdissected archival paraffin-embedded tissue from 16 SRCCCs and 27 non-SRCCCs was used to determine the frequency and pattern of mutation at codons 12, 13, and 61 of K-ras. A subset of tumors was examined for TP53 mutations at exons 5-8 and allele loss and genetic instability using seven microsatellite and two mononucleotide markers. Results: Comparable data on TP53 mutation, allele loss, and microsatellite instability were found between SRCCC and non-SRCCC. However, SRCCCs demonstrated a distinct pattern of K-ras mutation with a significantly lower frequency of mutations at codons 12 and 13 (13{\%} versus 48{\%}, P = 0.02) as compared with the non-SRCCCs. Four cases (25{\%}) of SRCCC demonstrated the same A:T transversion at the third base position of K-ras codon 61 (CAA to CAT; Gln to His). No such point mutation was detected in non-SRCCCs or in the 30 gastric and 4 urinary bladder signet ring cell carcinomas examined. Conclusions: Our findings suggest that a distinct pattern of K-ras mutation is present in SRCCC, including a specific codon 61 mutation that has rarely been reported in human neoplasms.",
author = "Wistuba, {Ignacio I.} and Carmen Behrens and Jorge Albores-Saavedra and Ruby Delgado and Francisco Lopez and Gazdar, {Adi F.}",
year = "2003",
month = "10",
day = "1",
language = "English (US)",
volume = "9",
pages = "3615--3619",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "10 I",

}

TY - JOUR

T1 - Distinct K-ras mutation pattern characterizes signet ring cell colorectal carcinoma

AU - Wistuba, Ignacio I.

AU - Behrens, Carmen

AU - Albores-Saavedra, Jorge

AU - Delgado, Ruby

AU - Lopez, Francisco

AU - Gazdar, Adi F.

PY - 2003/10/1

Y1 - 2003/10/1

N2 - Purpose: Signet ring cell colorectal carcinoma (SRCCC) represents a unique, infrequent, and highly malignant variant of colorectal cancer. To understand the pathogenesis of SRCCC, we investigated its molecular abnormalities and compared them with those of the usual type of colorectal adenocarcinoma. Experimental Design: Microdissected archival paraffin-embedded tissue from 16 SRCCCs and 27 non-SRCCCs was used to determine the frequency and pattern of mutation at codons 12, 13, and 61 of K-ras. A subset of tumors was examined for TP53 mutations at exons 5-8 and allele loss and genetic instability using seven microsatellite and two mononucleotide markers. Results: Comparable data on TP53 mutation, allele loss, and microsatellite instability were found between SRCCC and non-SRCCC. However, SRCCCs demonstrated a distinct pattern of K-ras mutation with a significantly lower frequency of mutations at codons 12 and 13 (13% versus 48%, P = 0.02) as compared with the non-SRCCCs. Four cases (25%) of SRCCC demonstrated the same A:T transversion at the third base position of K-ras codon 61 (CAA to CAT; Gln to His). No such point mutation was detected in non-SRCCCs or in the 30 gastric and 4 urinary bladder signet ring cell carcinomas examined. Conclusions: Our findings suggest that a distinct pattern of K-ras mutation is present in SRCCC, including a specific codon 61 mutation that has rarely been reported in human neoplasms.

AB - Purpose: Signet ring cell colorectal carcinoma (SRCCC) represents a unique, infrequent, and highly malignant variant of colorectal cancer. To understand the pathogenesis of SRCCC, we investigated its molecular abnormalities and compared them with those of the usual type of colorectal adenocarcinoma. Experimental Design: Microdissected archival paraffin-embedded tissue from 16 SRCCCs and 27 non-SRCCCs was used to determine the frequency and pattern of mutation at codons 12, 13, and 61 of K-ras. A subset of tumors was examined for TP53 mutations at exons 5-8 and allele loss and genetic instability using seven microsatellite and two mononucleotide markers. Results: Comparable data on TP53 mutation, allele loss, and microsatellite instability were found between SRCCC and non-SRCCC. However, SRCCCs demonstrated a distinct pattern of K-ras mutation with a significantly lower frequency of mutations at codons 12 and 13 (13% versus 48%, P = 0.02) as compared with the non-SRCCCs. Four cases (25%) of SRCCC demonstrated the same A:T transversion at the third base position of K-ras codon 61 (CAA to CAT; Gln to His). No such point mutation was detected in non-SRCCCs or in the 30 gastric and 4 urinary bladder signet ring cell carcinomas examined. Conclusions: Our findings suggest that a distinct pattern of K-ras mutation is present in SRCCC, including a specific codon 61 mutation that has rarely been reported in human neoplasms.

UR - http://www.scopus.com/inward/record.url?scp=0141456482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141456482&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 3615

EP - 3619

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 10 I

ER -